OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update

OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) saw a large drop in short interest in the month of September. As of September 15th, there was short interest totaling 21,300 shares, a drop of 31.3% from the August 31st total of 31,000 shares. Approximately 0.1% of the company's stock are short sold. Based on an average daily trading volume, of 131,500 shares, the short-interest ratio is currently 0.2 days. Based on an average daily trading volume, of 131,500 shares, the short-interest ratio is currently 0.2 days. Approximately 0.1% of the company's stock are short sold.

Institutional Trading of OKYO Pharma

Institutional investors have recently made changes to their positions in the business. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of OKYO Pharma during the 2nd quarter valued at about $28,000. FNY Investment Advisers LLC acquired a new position in OKYO Pharma in the first quarter valued at about $25,000. Finally, Dauntless Investment Group LLC acquired a new position in OKYO Pharma in the first quarter valued at about $2,526,000. 2.97% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of OKYO Pharma in a research note on Saturday, September 27th. Wall Street Zen upgraded shares of OKYO Pharma to a "hold" rating in a report on Saturday, August 9th. Zacks Research upgraded shares of OKYO Pharma to a "hold" rating in a report on Tuesday, September 16th. Finally, HC Wainwright restated a "buy" rating and set a $7.00 price target on shares of OKYO Pharma in a report on Tuesday, September 23rd. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $7.00.

OKYO Pharma Trading Up 3.5%

Shares of OKYO Pharma stock opened at $2.05 on Monday. The firm's 50-day simple moving average is $2.41 and its 200-day simple moving average is $2.07. OKYO Pharma has a twelve month low of $0.90 and a twelve month high of $3.35.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.